Skip to Main Content

Oncology Prenatal

Technology Publications

Working with us Open Positions

Mission, Vision, Values Leadership & Board Company Milestones

Press Releases Events Media Coverage Social Media

News & Media

All Categories

Media Coverage

Press Releases

General Information

All Years

2025

2024

2023

2022

2021

2020

2019

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Indianapolis family aims to help expecting parents fight disease affecting tens of thousands of Americans

Indianapolis family aims to help expecting parents fight disease affecting tens of thousands of Americans

Medicare Covering BillionToOne Northstar Select Cancer Liquid Biopsy Test

Medicare Covering BillionToOne Northstar Select Cancer Liquid Biopsy Test

BillionToOne Announces Medicare Coverage for Northstar Select®

BillionToOne Announces Medicare Coverage for Northstar Select®

BillionToOne Celebrates Major Milestone: 1 Million UNITY Tests

BillionToOne Celebrates Major Milestone: 1 Million UNITY Tests

Methylation Monitoring Predicts Pan-Cancer Outcomes

Methylation Monitoring Predicts Pan-Cancer Outcomes

Forbes: 2025 Best Startup Employers

Forbes: 2025 Best Startup Employers

BillionToOne's Northstar Response® Validated in New Peer-Reviewed Study, Building on Previous Clinical Research

BillionToOne's Northstar Response® Validated in New Peer-Reviewed Study, Building on Previous Clinical Research

February 28, 2025

BillionToOne Study Lays Out Evidence for NIPT Fetal RhD Detection Accuracy

February 28, 2025

BillionToOne Study Lays Out Evidence for NIPT Fetal RhD Detection Accuracy

Social Posts

Follow us

We are ONE team, working
toward ONE goal — to detect
disease ONE molecule at a time.

X formerly Twitter

What We Offer

Our Technology Publications Products

Explore

News & Media Press Releases Media Coverage Events

About Us

Careers Patient Portal IT Security Compliance

Contact

Contact Information

Privacy Policy Notice of Privacy Practices Accessibility Statement TERMS OF USE

ACCREDITATIONS UNION CITY:
CA: CDF-00353741
CAP: 8643216
CLIA: 05D2167800
MD: 2999
PA: 37021
RI: LCO01671
DC: HFD-OS29
NYSDOH: 9828
ACCREDITATIONS MENLO PARK:
CA: CDF-90008579
CAP: 9568790
CLIA: 05D2275351
MD: 3855
PA: 40795
RI: LCO01700
DC: HFD-OS43
PATENT MARKINGS

© 2026 BillionToOne Inc.
All rights reserved.